Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Study Phase : Discovery Platform
Sponsor : Rondo Therapeutics
Deal Size : Undisclosed
Deal Type : Licensing Agreement
AbTherx and Rondo Therapeutics Announce Multi-Program Antibody Discovery Collaboration
Details : Under the terms of the licensing agreement, Rondo has the right to develop and commercialize therapeutic antibodies resulting from the collaboration.
Product Name : Undisclosed
Product Type : Antibody
Upfront Cash : Undisclosed
April 23, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Highest Development Status : Discovery Platform
Sponsor : Rondo Therapeutics
Deal Size : Undisclosed
Deal Type : Licensing Agreement